China Medical Technologies Receives SFDA Approval for HPV Chip | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – China Medical Technologies said today it has received approval of its surface plasmon resonance-based HPV-DNA chip from the State Food and Drug Administration of China.

The chip can detect high-risk and low-risk genotypes by analyzing a patient sample on the company's fully automated SPR analyzer, Beijing-based China Medical Technologies said in a statement. It added that the chip can distinguish multiple human papillomavirus infections and determine the viral load.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.